# The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

> **NCT01187238** · PHASE2 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 84 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT01187238
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-07
- **Final completion:** 2017-10
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2020-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01187238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01187238, "The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01187238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*